COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,726 Articles (22,502 medRxiv, 8,224 bioRxiv)

Most recent first Previous |  Page 1467: Articles 14661-14670  | Next

Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice
Salzer, R., Clark, J. J., Vaysburd, M., Chang, V. T., Albecka-Moreau, A., Kiss, L., Sharma, P., Gonzalez Llamazares, A., Kipar, A., Hiscox, J. A., Owen, A., Aricescu, A. R., Stewart, J. P., James, L. C., Lowe, J.
10.1101/2021.05.18.444622 — Posted: 2021-05-18
In Silico Molecular-Based Rationale for SARS-CoV-2 Spike Circulating Mutations Able to Escape Bamlanivimab and Etesevimab Monoclonal Antibodies
Laurini, E., Marson, D., Aulic, S., Fermeglia, A., PRICL, S.
10.1101/2021.05.18.444605 — Posted: 2021-05-18
Effect of COVID-19 on inequalities in premature mortality in England: an analysis of excess mortality by deprivation and ethnicity
Barnard, S., Fryers, P., Fitzpatrick, J., Fox, S., Baker, A., Burton, P., Newton, J., Doyle, Y., Goldblatt, P.
10.1101/2021.05.18.21256717 — Posted: 2021-05-18
Early Anakinra Treatment for COVID-19 Guided by Urokinase Plasminogen Receptor
Kyriazopoulou, E., Poulakou, G., Milionis, H., Metallidis, S., Adamis, G., Tsiakos, K., Fragkou, A., Rapti, A., Danoulari, C., Fantoni, M., Kalomenidis, I., Chrysos, G., Angheben, A., Kainis, I., Alexiou, Z., Castelli, F., Serino, F. S., Bakakos, P., Nicastri, E., Tzavara, V., Kostis, E., Dagna, L., Koufargyris, P., Dimakou, K., Tzatzagou, G., Chini, M., Bassetti, M., Katrini, K., Kotsis, V., Tsoukalas, G., Selmi, C., Bliziotis, I., Samarkos, M., Doumas, M., Ktena, S., Masgala, A., Papanikolaou, I., Argyraki, A., Cardellino, C. S., Katsigianni, E.-I., Giannitsioti, E., Cingolani, A., Akinosogl
10.1101/2021.05.16.21257283 — Posted: 2021-05-18
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Campbell, M., Spata, E., Emberson, J. R., Staplin, N., Pessoa-Amorim, G., Peto, L., Wiselka, M., Wiffen, L., Tiberi, S., Caplin, B., Wroe, C., Green, C., Hine, P., Prudon, B., George, T., Wight, A., Baillie, J. K., Basnyat, B., Buch, M. H., Chappell, L. C., Day, J. N., Faust, S. N., Hamers, R. L., Jaki, T., Juszczak, E., Jeffery, K., Lim, W. S., Montgomery, A., Mumford, A., Rowan, K., Thwaites, G., Mafham, M., Haynes, R., Landray, M. J.
10.1101/2021.05.18.21257267 — Posted: 2021-05-18
SPEEDS: A Portable Serological Testing Platform for Rapid Electrochemical Detection of SARS-CoV-2 Antibodies
Peng, R., Pan, Y., Li, Z., Qin, Z., Rini, J. M., Liu, X.
10.1101/2021.05.16.21256907 — Posted: 2021-05-18
Indian Interventional trials for COVID-19 drugs: Insights and Learnings
Ranade, A. N., Wani, K., Venugopalan, P., Lele, C., Kale, S. S.
10.1101/2021.05.16.21257299 — Posted: 2021-05-18
Reduction in COPD exacerbations during COVID-19: a systematic review and meta-analysis
Alqahtani, J. S., Oyelade, T., Aldhahir, A. M., Mendes, R. G., Alghamdi, S. M., Miravitlles, M., Mandal, S., Hurst, J. R.
10.1101/2021.05.17.21257335 — Posted: 2021-05-18
Microsimulation of SARS-CoV-2 Transmission in Society
Green, A. R., Keep, D., Piper, I.
10.1101/2021.05.16.21257298 — Posted: 2021-05-18
Predisposing factors associated with the severity of the illness in adults with Covid-19 in Nepal.
Jha, R. K., Shrestha, A., Tamang, B., K.C., I., Sah, S. K.
10.1101/2021.05.16.21257280 — Posted: 2021-05-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).